Analysts Are Bullish on Top Healthcare Stocks: Outset Medical (OM), CVS Health (CVS)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Outset Medical (OM) and CVS Health (CVS) with bullish sentiments.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Outset Medical (OM)
In a report released today, Josh Jennings from TD Cowen reiterated a Buy rating on Outset Medical, with a price target of $12.00. The company’s shares closed last Monday at $4.08.
According to TipRanks.com, Jennings is a 3-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Outset Medical with a $10.50 average price target.
See today’s best-performing stocks on TipRanks >>
CVS Health (CVS)
In a report released today, Charles Rhyee from TD Cowen reiterated a Buy rating on CVS Health, with a price target of $105.00. The company’s shares closed last Monday at $73.28.
According to TipRanks.com, Rhyee is a 3-star analyst with an average return of
Currently, the analyst consensus on CVS Health is a Strong Buy with an average price target of $96.33, which is a 31.1% upside from current levels. In a report issued on March 30, Bernstein also maintained a Buy rating on the stock with a $94.00 price target.
Read More on OM:
Disclaimer & DisclosureReport an Issue
- Outset Medical: Tablo Platform’s System‑Wide Insights Drive Strategic Health System Adoption and Support Buy Rating
- Outset Medical Earnings Call Highlights Margin Turnaround
- Outset Medical price target lowered to $12 from $15 at TD Cowen
- Outset Medical price target lowered to $15 from $17 at BTIG
- Outset Medical: Improving Visibility, Stronger Margins, and Next-Gen Tablo Support Buy Rating and $15 Target
